Who owns MEDICINOVA INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MNOV from SEC Form 13F filings across 38 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 38 institutions disclosed 8.5M shares of MEDICINOVA INC worth $14.3M — about 17.2% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
38
13F holders
$14.3M
value, 2026 filers
17.2%
of shares outstanding (8.5M sh)
10
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MNOV's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 3.2M | $5.4M | 0.0% | 6.6% | +431.5% |
| 2 | Essex Woodlands Management, Inc. | 1.1M | $1.9M | 0.6% | 2.2% | 0.0% |
| 3 | BlackRock, Inc. | 744,685 | $1.2M | 0.0% | 1.5% | -1.0% |
| 4 | GOLDMAN SACHS GROUP INCNEW | 615,863 | $1.0M | 0.0% | 1.2% | new |
| 5 | CITIGROUP INC | 549,094 | $919,732 | 0.0% | 1.1% | -13.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 522,222 | $874,973 | 0.0% | 1.1% | -3.2% |
| 7 | VANGUARD FIDUCIARY TRUST CO | 296,204 | $496,142 | 0.0% | 0.6% | +4.8% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 224,595 | $376,197 | 0.0% | 0.5% | +9.3% |
| 9 | STATE STREET CORP | 193,698 | $324,444 | 0.0% | 0.4% | 0.0% |
| 10 | NORTHERN TRUST CORP | 143,580 | $240,497 | 0.0% | 0.3% | -0.1% |
| 11 | JANE STREET GROUP, LLC | 126,987 | $212,703 | 0.0% | 0.3% | +702.8% |
| 12 | TWO SIGMA INVESTMENTS, LP | 124,160 | $207,968 | 0.0% | 0.3% | +817.9% |
| 13 | Bank of New York Mellon Corp | 78,277 | $131,114 | 0.0% | 0.2% | 0.0% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 71,506 | $119,773 | 0.0% | 0.1% | 0.0% |
| 15 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,214 | $92,483 | 0.0% | 0.1% | -1.5% |
| 16 | SBI Securities Co., Ltd. | 53,389 | $89,427 | 0.0% | 0.1% | +3.7% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 50,552 | $84,675 | 0.0% | 0.1% | 0.0% |
| 18 | Empowered Funds, LLCNEW | 49,430 | $82,795 | 0.0% | 0.1% | new |
| 19 | UBS Group AG | 36,326 | $60,846 | 0.0% | 0.1% | -83.7% |
| 20 | CITADEL ADVISORS LLCNEW | 35,455 | $59,387 | 0.0% | 0.1% | new |
| 21 | Schonfeld Strategic Advisors LLC | 27,961 | $46,834 | 0.0% | 0.1% | -22.7% |
| 22 | BARCLAYS PLC | 23,735 | $39,756 | 0.0% | 0% | -44.6% |
| 23 | Qube Research & Technologies LtdNEW | 23,648 | $39,610 | 0.0% | 0% | new |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 19,295 | $32,319 | 0.0% | 0% | -27.9% |
| 25 | XTX Topco LtdNEW | 18,643 | $31,227 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.